{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:04:57Z","timestamp":1779433497781,"version":"3.53.1"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic inflammation is a well-documented feature of human immunodeficiency virus (HIV) infection and is implicated in the progression of several comorbidities, including chronic kidney disease (CKD). Notably, chronic coagulation activation is another common phenomenon mediated by chronic inflammation among people living with HIV (PLWH) and has also been linked to CKD progression. However, the relationship between inflammation, coagulation and renal dysfunction remains underexplored in African populations with high HIV prevalence. This study investigated the association between systemic inflammation, coagulation activation and renal function among PLWH, particularly those receiving antiretroviral therapy (ART).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this cross-sectional study, 151 adults were enrolled, comprising 80 PLWH on ART, 27 PLWH not on ART, and 44 people not living with HIV (PNLWH). Inflammatory marker, C-reactive protein (CRP) and coagulation markers including fibrinogen and D-dimer, were measured and CKD stages were determined using estimated glomerular filtration rate (eGFR), which was calculated based on cystatin C (cystC) levels (eGFR\n                      <jats:sub>cystC<\/jats:sub>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the overall PLWH cohort, D-dimer was significantly associated with reduced eGFR\n                      <jats:sub>cystC<\/jats:sub>\n                      in both crude (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.004) and adjusted analyses (\n                      <jats:italic>p<\/jats:italic>\n                      =\u00a00.014), indicating poorer kidney function. Fibrinogen showed a significant association with reduced eGFR\n                      <jats:sub>cystC<\/jats:sub>\n                      only after adjusting for confounders (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.048). Among PLWH on ART, D-dimer remained independently associated with reduced eGFR\n                      <jats:sub>cystC<\/jats:sub>\n                      , while fibrinogen showed an independent association after adjustment (\u03b2 = -1.54,\n                      <jats:italic>p<\/jats:italic>\n                      =\u00a00.031). Elevated fibrinogen levels were associated with an increased odds of CKD in the overall PLWH group (AOR\u00a0=\u00a01.12, 95% CI 1.00\u20131.23,\n                      <jats:italic>p<\/jats:italic>\n                      =\u00a00.0 41), and elevated D-dimer levels were associated with increased odds of CKD among those on ART (AOR\u00a0=\u00a01.01, 95% CI 1.00\u20131.03,\n                      <jats:italic>p<\/jats:italic>\n                      =\u00a00.045).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The study reveals that both D-dimer and fibrinogen, key markers of coagulation are independently associated with renal function decline and risk of CKD in PLWH, particularly those on ART. These findings suggest that coagulation activation may be an early indicator of declining kidney function and increased risk of CKD in PLWH, potentially preceding overt systemic inflammation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneph.2026.1800778","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:08:31Z","timestamp":1779430111000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Coagulation is associated with renal function decline and chronic kidney disease in people living with HIV in South Africa"],"prefix":"10.3389","volume":"6","author":[{"given":"Joel","family":"Choshi","sequence":"first","affiliation":[{"name":"Department of Physiology and Environmental Health, University of Limpopo","place":["Sovenga, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haskly","family":"Mokoena","sequence":"additional","affiliation":[{"name":"Department of Physiology and Environmental Health, University of Limpopo","place":["Sovenga, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihle E.","family":"Mabhida","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Health Systems Research Unit, South African Medical Research Council","place":["Tygerberg, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Flepisi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmacology, University of the Witwatersrand","place":["Braamfontein, Johannesburg, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen C.","family":"Steel","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Pretoria","place":["Pretoria, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabelo","family":"Mokgalaboni","sequence":"additional","affiliation":[{"name":"Department of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa","place":["Roodepoort, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy N.","family":"Phoswa","sequence":"additional","affiliation":[{"name":"Department of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa","place":["Roodepoort, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Maarman","sequence":"additional","affiliation":[{"name":"Centre for Cardio-Metabolic Research in Africa (CARMA), Division of Medical Physiology, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Stellenbosch University","place":["Cape Town, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongani B.","family":"Nkambule","sequence":"additional","affiliation":[{"name":"School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal","place":["Durban, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phiwayinkosi V.","family":"Dludla","sequence":"additional","affiliation":[{"name":"School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal","place":["Durban, South Africa"]},{"name":"Department of Biochemistry and Microbiology, University of Zululand","place":["KwaDlangezwa, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney","family":"Hanser","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, Sefako Makgatho Health Sciences University","place":["Tshwane, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04011-8","article-title":"Kidney dysfunction and associated factors among adults living with human immuno-deficiency virus in Africa: a systematic review and meta-analysis","volume":"26","author":"Tassew","year":"2025","journal-title":"BMC Nephrol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/23259582221089194","article-title":"Impact of antiretroviral therapy on kidney disease in HIV infected individuals\u2013a qualitative systematic review","volume":"21","author":"Adnani","year":"2022","journal-title":"J Int Assoc Providers AIDS Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jana.2018.04.004","article-title":"Chronic kidney disease in persons living with HIV: a systematic review","volume":"29","author":"Park","year":"2018","journal-title":"J Assoc Nurses AIDS Care"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.124.323948","article-title":"Cardiac and renal comorbidities in aging people living with HIV","volume":"134","author":"McCutcheon","year":"2024","journal-title":"Circ Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.24884\/1561-6274-2018-22-6-84-100","article-title":"Kidney disease in the setting of HIV infection: conclusions from a kidney disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"93","author":"Swanepoel","year":"2018","journal-title":"Kidney Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev.bioeng.8.061505.095708","article-title":"Analysis of inflammation","volume":"8","author":"Schmid-Sch\u00f6nbein","year":"2006","journal-title":"Annu Rev BioMed Eng"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eursup.2006.02.003","article-title":"Inflammation, apoptosis, and BPH: what is the evidence","volume":"5","author":"Novara","year":"2006","journal-title":"Eur Urol Suppl"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7316456","article-title":"HIV\u2010related immune activation and inflammation: current understanding and strategies","volume":"2021","author":"Lv","year":"2021","journal-title":"J Immunol Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v14.i3.130","article-title":"Pancreatic \u03b2-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress","volume":"14","author":"Dludla","year":"2023","journal-title":"World J Diabetes"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09594-5","article-title":"A systematic review assessing the association of inflammatory markers with kidney dysfunction in people living with HIV on highly active antiretroviral therapy","volume":"24","author":"Choshi","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PloS Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000001461","article-title":"Activation, senescence and inflammation markers in HIV patients: association with renal function","volume":"31","author":"Ozanne","year":"2017","journal-title":"AIDS"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv159","article-title":"Kidney dysfunction and markers of inflammation in the Multicenter AIDS Cohort Study","volume":"212","author":"Abraham","year":"2015","journal-title":"J Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12268","article-title":"Markers of renal disease and function are associated with systemic inflammation in HIV infection","volume":"16","author":"Gupta","year":"2015","journal-title":"HIV Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09050-4","article-title":"High-sensitivity C-reactive protein among people living with HIV on highly active antiretroviral therapy: a systemic review and meta-analysis","volume":"24","author":"Mabhida","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044454","article-title":"Inflammation, coagulation and cardiovascular disease in HIV-infected individuals","volume":"7","author":"Duprez","year":"2012","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis406","article-title":"HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation","volume":"55","author":"Armah","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59101826","article-title":"Trends of coagulation parameters in human immunodeficiency virus patients","volume":"59","author":"Bashir","year":"2023","journal-title":"Medicina"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cells13080672","article-title":"HIV infection, antiretroviral drugs, and the vascular endothelium","volume":"13","author":"Kanmogne","year":"2024","journal-title":"Cells"},{"key":"B21","volume-title":"Coagulation abnormalities play a central role in HIV comorbidities and should be therapeutically targeted","author":"He","year":"2018"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1002652","article-title":"C-reactive protein, immunothrombosis and venous thromboembolism","volume":"13","author":"Dix","year":"2022","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14049","article-title":"Association between fibrinogen\u2010to\u2010albumin ratio and prognosis of patients with heart failure","volume":"53","author":"Xu","year":"2023","journal-title":"Eur J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2017.08.039","article-title":"The hypercoagulability paradox of chronic kidney disease: The role of fibrinogen","volume":"214","author":"Nunns","year":"2017","journal-title":"Am J Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000528693","article-title":"Role of C-reactive protein in kidney diseases","volume":"9","author":"Li","year":"2023","journal-title":"Kidney Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1425460","article-title":"Prevalence of chronic kidney disease and associated risk factors among people living with HIV in a rural population of Limpopo Province, South Africa","volume":"12","author":"Choshi","year":"2024","journal-title":"Front Public Health"},{"key":"B27","volume-title":"Pathogenesis of anti-HIV drug (TENOFOVIR) induced renal damage: possible roles of oxidative stress, nitrosative stress and nf-kb pathway","author":"Hemalatha","year":"2013"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010263","article-title":"Inflammation and oxidative stress in chronic kidney disease\u2014potential therapeutic role of minerals, vitamins and plant-derived metabolites","volume":"21","author":"Rapa","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111309","article-title":"Concomitant administration of HAART aggravates anti-Koch-induced oxidative hepatorenal damage via dysregulation of glutathione and elevation of uric acid production","volume-title":"Biomed Pharmacother","author":"Hamed","year":"2021"},{"key":"B30","unstructured":"The sixth South African National HIV Prevalence, Incidence, Behaviour and Communication Survey (SABSSM VI): 20 years of strategic HIV and public health data\n          \n          \n            \n              Zuma\n              K\n            \n          \n          \n          2023"},{"key":"B31","unstructured":"Ranking of countries with the highest prevalence of HIV in 2000 and 2024\n          \n          \n          \n          2024"},{"key":"B32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/978-981-13-8871-2_29","article-title":"Oxidative stress and renal fibrosis: mechanisms and therapies","volume-title":"Renal fibrosis: mechanisms and therapies","author":"Su","year":"2019"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24875\/aidsrev.20000039","article-title":"The effect of successful antiretroviral therapy on immune activation and reconstitution in HIV-infected adults: a systematic review and meta-analysis","volume":"23","author":"Nyambuya","year":"2021","journal-title":"AIDS Rev"},{"key":"B34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/med\/9780190942496.003.0022","article-title":"Initiation of antiretroviral therapy","volume-title":"Fundamentals of HIV medicine 2019: CME edition","author":"Ajmal","year":"2019"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2024.02.006","article-title":"The role of thromboinflammation in acute kidney injury among patients with septic coagulopathy","volume":"22","author":"Iba","year":"2024","journal-title":"J Thromb Haemostasis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112737","article-title":"Tissue factor, thrombosis, and chronic kidney disease","volume":"10","author":"Oe","year":"2022","journal-title":"Biomedicines"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04077-4","article-title":"Molecular mechanisms and therapeutic interventions in acute kidney injury: a literature review","volume":"26","author":"He","year":"2025","journal-title":"BMC Nephrol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1159\/000502898","article-title":"Associations of urine biomarkers with kidney function decline in HIV-infected and uninfected men","volume":"50","author":"Ascher","year":"2019","journal-title":"Am J Nephrol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.01.027","article-title":"Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study","volume":"51","author":"Jones","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0b013e31826a6c4f","article-title":"Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals","volume":"61","author":"Inker","year":"2012","journal-title":"J Acquired Immune Deficiency Syndromes"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1295217","article-title":"A systematic review assessing the potential use of cystatin c as a biomarker for kidney disease in people living with HIV on antiretroviral therapy","volume":"11","author":"Hanser","year":"2024","journal-title":"Front Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42452-024-06197-2","article-title":"Assessing renal function with the use of cystatin C in a rural cohort of people living with HIV on highly active antiretroviral therapy within the Limpopo Province, South Africa","volume":"6","author":"Choshi","year":"2024","journal-title":"Discover Appl Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1963.tb13293.x","article-title":"Methodological problems in the study of human populations","volume":"107","author":"Cochran","year":"1963","journal-title":"Ann N Y Acad Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.5124\/jkma.25.0052","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"J Am Med Assoc"},{"key":"B45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/01.jaa.0000800284.39341.3b","article-title":"Reevaluating race and the glomerular filtration rate calculator","volume":"34","author":"Lyas","year":"2021","journal-title":"JAAPA"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-230","article-title":"Perceptions and use of the national kidney foundation KDOQI guidelines: a survey of US renal healthcare providers","volume":"14","author":"Estrella","year":"2013","journal-title":"BMC Nephrol"},{"key":"B47","article-title":"Dyslipidemia in chronic kidney disease","author":"Rosenstein","year":"2022","journal-title":"Endotext [internet]"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-210179","article-title":"Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation","volume":"115","author":"Funderburg","year":"2010","journal-title":"Blood J Am Soc Hematol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2012.0034","article-title":"Initiation of an abacavir-containing regimen in HIV-infected adults is associated with a smaller decrease in inflammation and endothelial activation markers compared to non-abacavir-containing regimens","volume":"28","author":"Hileman","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-7-9","article-title":"Markers of inflammation and coagulation indicate a prothrombotic state in HIV-infected patients with long-term use of antiretroviral therapy with or without abacavir","volume":"7","author":"Jong","year":"2010","journal-title":"AIDS Res Ther"},{"key":"B51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12981-024-00665-w","article-title":"Brief communication: coagulation profiles of HIV positive patients on antiretroviral therapy (ART) at the Mampong Municipal Hospital, Ashanti-Region, Ghana: a case control study","volume":"21","author":"Opoku","year":"2024","journal-title":"AIDS Res Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2014.01.008","article-title":"Persistent inflammation in HIV infection: established concepts, new perspectives","volume":"161","author":"Nasi","year":"2014","journal-title":"Immunol Lett"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/hiv.12952","article-title":"Managing HIV\u2010associated inflammation and ageing in the era of modern ART","volume":"21","author":"Bloch","year":"2020","journal-title":"HIV Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/qai.0b013e3181f7f61a","article-title":"Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection","volume":"56","author":"Baker","year":"2011","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu254","article-title":"Soluble markers of inflammation and coagulation but not T-cell activation predict non\u2013AIDS-defining morbid events during suppressive antiretroviral treatment","volume":"210","author":"Tenorio","year":"2014","journal-title":"J Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix202","article-title":"Higher prevalence and faster progression of chronic kidney disease in human immunodeficiency virus\u2013infected middle-aged individuals compared with human immunodeficiency virus\u2013uninfected controls","volume":"216","author":"Kooij","year":"2017","journal-title":"J Infect Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9080752","article-title":"Chronic kidney disease as oxidative stress-and inflammatory-mediated cardiovascular disease","volume":"9","author":"Podkowi\u0144ska","year":"2020","journal-title":"Antioxidants"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/life11050419","article-title":"Chronic kidney disease as a systemic inflammatory syndrome: update on mechanisms involved and potential treatment","volume":"11","author":"Tinti","year":"2021","journal-title":"Life"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000000545","article-title":"The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation","volume":"29","author":"Wada","year":"2015","journal-title":"Aids"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0000000000000557","article-title":"Reductions in plasma cystatin C after initiation of antiretroviral therapy are associated with reductions in inflammation: ACTG A5224s","volume":"69","author":"Longenecker","year":"2015","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.13121215","article-title":"Inflammation and progression of CKD: the CRIC study","volume":"11","author":"Amdur","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155100","article-title":"Relevance of interleukin-6 and D-dimer for serious non-AIDS morbidity and death among HIV-positive adults on suppressive antiretroviral therapy","volume":"11","author":"Grund","year":"2016","journal-title":"PloS One"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090978","article-title":"Factors associated with D-dimer levels in HIV-infected individuals","volume":"9","author":"Borges","year":"2014","journal-title":"PloS One"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/jalm\/jfaa047","article-title":"D-dimer and fibrin degradation products impair platelet signaling: plasma D-dimer is a predictor and mediator of platelet dysfunction during trauma","volume":"5","author":"Verni","year":"2020","journal-title":"J Appl Lab Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1515\/hmbci-2022-0093","article-title":"D-dimer\u2013a multifaceted molecule","volume":"45","author":"Tayal","year":"2024","journal-title":"Hormone Mol Biol Clin Invest"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107812","article-title":"HIV infection, antiretroviral therapy and vascular dysfunction: Effects, mechanisms and treatments","volume":"217","author":"Wei","year":"2025","journal-title":"Pharmacol Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1097\/ms9.0000000000003714","article-title":"Hematological disruptions in HIV-positive individuals with cardiac arrhythmias: a focus on coagulation and inflammation\u2013a narrative review","volume":"87","author":"Obeagu","year":"2025","journal-title":"Ann Med Surg"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.77509","article-title":"A comprehensive review of the manifestation of cardiovascular diseases in HIV patients","volume":"17","author":"Abarca","year":"2025","journal-title":"Cureus"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2026.1800778\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:08:35Z","timestamp":1779430115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2026.1800778\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":68,"alternative-id":["10.3389\/fneph.2026.1800778"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2026.1800778","relation":{},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"article-number":"1800778"}}